Latest From Biotech Now

BIO Congratulates BioGENEius Winners!

2015 BioGENEius Challenge Winners

The 2015 International BIO Convention brought together some of the top biotechnology experts from around the world - some of whom are still in high school! BIO would like to congratulate, Anvita Gupta and Austin Wang, the winners of the annual International BioGENEius Challenge – the premier competition for high school students that recognizes outstanding innovation in biotechnology! Anvita (12th Grade, Scottsdale, Arizona) won the Global Healthcare category for her project titled, Novel Therapeutics for Genetic Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO 2015 Provides Local Shoe Shiner with School Supplies for Kids in Need

AbbVie3

For the past decade, William Green, a center city shoe shiner, hosts a Children’s Cookout and Day of Fun in late August for poverty stricken children in Philadelphia. In addition to providing a day of safe fun for local children, “Big Will’s” cookout provides an opportunity to supply book bags and school supplies to more than 500 needy students throughout the city. Today, the 2015 BIO International Convention provided “Big Will” with over 500 hundred Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Riding the Bull Market: What’s in Store for Biotech Dealmakers in 2015?

72263479

In many ways, 2014 was a record year for biopharma dealmaking, with $355 billion in total transactions, including $53 billion in partnering deals, $16.5 billion in venture investments and 133 IPOs. According to the 2015 Campbell Alliance Dealmakers’ Intentions Study, 2015 is shaping up to be the year of historic M&A in the biopharmaceutical sector, driven in part by greater access to capital. The partnering numbers at BIO 2015 further indicate that the appetite for Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

The Next Step: How Companies Build Successful Therapeutic Franchises from the Ground Up

Building a new franchise in a therapeutic from scratch poses a host of challenges, from whether to take the risk of entering a new area at all to whether and how to partner strategically with another company. It’s a challenge for both the biggest biopharma companies and emerging biotechs to evaluate how and when to enter new therapeutic areas and to try to ensure that their efforts will not only help patients in need but Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

How to Grow a Sustainable Biotech Company? Three Success Stories

Sustainable Biotech Company

Katrine Bosley, CEO of Editas Medicine kicked off the session by introducing panelists from three biotech firms with drug candidates in various stages: Arndt Schottelius, CDO of MorphoSys,  Loredana Ablondi, Licensing Manager of Chiesi Farmaceutici SpA (Cheisi) and Andre Hoekema, Senior Vice President of Corporate Development at Galapagos NV. The panelists spoke about the importance of critical alliances which enabled them to grow their companies, and the possibilities that emerged from them. For MorphaSys, this Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,